Karen E. Knudsen, MBA, PhD, is executive vice president of oncology services and enterprise director of the Sidney Kimmel Cancer Center (SKCC) at Jefferson, one of only 70 National Cancer Institute designated centers. Dr. Knudsen oversees cancer research and cancer patient care across Jefferson Health, and SKCC is consistently ranked as one of the top centers for cancer care in the nation. Dr. Knudsen also serves as chair of the Department of Cancer Biology at the Thomas Jefferson University, and holds joint appointments in the departments of Urology, Medical Oncology, and Radiation Oncology. Dr. Knudsen’s expertise is in developing new means to treat advanced prostate cancer, and discovering genetic alterations that contribute to disease progression. Dr. Knudsen is active in the field, serving as the editor-in-chief of Molecular Cancer Research, as president-elect of AACI, holds leadership roles in national organizations including ASCO, and serves on the NCI Board of Scientific Advisors.